This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.
Original paper

Why Is Aducanumab Priced at $56,000 per Patient? Lessons for Drug-Pricing Reform

Volume: 385, Issue: 22, Pages: 2017 - 2019
Published: Nov 20, 2021
Abstract
Interview with Dr. James Robinson on the aducanumab experience and the structural factors responsible for high drug prices in the United States. (10:44)Download Aducanumab's price can inform the drug-pricing policy debate because it responds to key features of the market environment for physician-administered drugs: Medicare's reimbursement formula, payment to physicians for infused drugs, and cost-sharing...
Paper Details
Title
Why Is Aducanumab Priced at $56,000 per Patient? Lessons for Drug-Pricing Reform
Published Date
Nov 20, 2021
Volume
385
Issue
22
Pages
2017 - 2019
© 2025 Pluto Labs All rights reserved.
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.